top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
38779-0195-06 | J7624 | BETAMETHASONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | BETAMETHASONE SODIUM PHOSPHATE (U.S.P.) | NA |
38779-0195-06 | J7624 | BETAMETHASONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | BETAMETHASONE SODIUM PHOSPHATE (U.S.P.) | NA |
38779-0198-00 | J7627 | BUDESONIDE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, UP TO 0.5 MG | BUDESONIDE (MICRONIZED) | NA |
38779-0198-00 | J7627 | BUDESONIDE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, UP TO 0.5 MG | BUDESONIDE (MICRONIZED) | NA |
47335-0892-74 | None | TEMOZOLOMIDE, 100 MG, ORAL | TEMOZOLOMIDE (1X5,HARD GELATIN) 100 MG | PO |
47335-0892-80 | None | TEMODAR, 100 MG, ORAL | TEMOZOLOMIDE (HARD GELATIN) 100 MG | PO |
47335-0893-74 | None | TEMOZOLOMIDE, 250 MG, ORAL | TEMOZOLOMIDE (1X5,HARD GELATIN) 250 MG | PO |
47335-0893-80 | None | TEMODAR, 250 MG, ORAL | TEMOZOLOMIDE (HARD GELATIN) 250 MG | PO |
47335-0895-40 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (USP,SDV) 20 MG/1 ML | IV |
47335-0929-21 | None | TEMODAR, 20 MG, ORAL | TEMOZOLOMIDE (HARD GELATIN) 140 MG | PO |
47335-0929-72 | None | TEMOZOLOMIDE, 20 MG, ORAL | TEMOZOLOMIDE (3X5,HARD GELATIN) 140 MG | PO |
47335-0929-74 | None | TEMOZOLOMIDE, 20 MG, ORAL | TEMOZOLOMIDE (1X5,HARD GELATIN) 140 MG | PO |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page